Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Abevmy® Page last updated: 4 March 2022 Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 306KB) Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 45KB)